Varenicline, a new treatment option in smoking cessation
Authors
Abstract
Varenicline is a well‐tolerated novel treatment to aid smoking cessation in adults that is generally more effective than existing smoking cessation aids. In our New products review Steve Chaplin presents the clinical trial results relating to its efficacy and adverse effects, and Professor Robert West comments on its place in smoking cessation. Copyright © 2007 Wiley Interface Ltd
Digital Object Identifier (DOI)
10.1002/psb.135 About DOI
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Wiley Job Network






